A potential therapeutic for treatment of HIV/AIDS

Technology Overview: ：
The invention is a potential HIV therapy that specifically targets the human immune deficiency virus type 1 (HIV-1).

Advantages： 
1.Potentially long-term suppression of HIV gene expression
2.Less susceptible to gene mutations and thus resistance compared to post-transcriptional targets
3.Does not require long-term daily dosage regimes with adverse side effects

Applications:
HIV therapy

Cooperative Intent:
UNSW is seeking a commercial partner to licence and/or to work collaboratively with the inventors at the highly respected UNSW Kirby Institute for Infection and Immunity in Society